• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Akorn, Inc. (AKRX)

    -NasdaqGS
    36.91 Up 0.44(1.21%) Dec 26, 4:00PM EST
    |After Hours : 36.91 Up 0.00 (0.01%) Dec 26, 4:44PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Akorn, Inc.
    1925 West Field Court
    Suite 300
    Lake Forest, IL 60045
    United States - Map
    Phone: 847-279-6100
    Website: http://www.akorn.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:1,099

    Business Summary 

    Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, vaccines, and others. The company operates in three segments: Ophthalmic, Hospital Drugs & Injectables, and Contract Services. The Ophthalmic segment markets diagnostic products, such as mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others for use in the office setting; therapeutic products, including antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; non-pharmaceutical products comprising artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers; and over-the-counter dry eye and other eye health products under the TheraTears name through chain drug stores and big box retailers, as well as directly to optometrists, ophthalmologists, and other eye care practitioners and clinics. This segment offers ophthalmic products, such as AzaSite, an azithromycin ophthalmic solution; Cosopt, a dorzolamide hydrochloride and timolol maleate ophthalmic solution; and Cosopt PF, a preservative-free prescription version of Cosopt. The Hospital Drugs & Injectables segment provides hospital drug and injectable pharmaceutical products comprising antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other pharmaceutical products to hospitals through the wholesale distribution channel. The Contract Services segment manufactures various pharmaceutical products for third party pharmaceutical customers based on their specifications. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Akorn, Inc.

    Corporate Governance 
    Akorn, Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 4; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Rajat Rai , 47
    Chief Exec. Officer
    1.25M0.00
    Mr. Timothy A. Dick , 44
    Chief Financial Officer and Principal Accounting Officer
    399.00K0.00
    Dr. Bruce Kutinsky Pharm.D., 48
    Chief Operating Officer
    445.00K0.00
    Mr. Joseph Bonaccorsi , 49
    Sr. VP, Gen. Counsel and Sec.
    413.00K0.00
    Mr. John R. Sabat , 64
    Sr. VP of National Accounts and Trade Relations
    369.00K0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders